Advertisement

Topics

Latest "Patient Privacy Rights Foundation" News Stories

23:32 EDT 17th October 2018 | BioPortfolio

Here are the most relevant search results for "Patient Privacy Rights Foundation" found in our extensive news archives from over 250 global news sources.

More Information about Patient Privacy Rights Foundation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Patient Privacy Rights Foundation for you to read. Along with our medical data and news we also list Patient Privacy Rights Foundation Clinical Trials, which are updated daily. BioPortfolio also has a large database of Patient Privacy Rights Foundation Companies for you to search.

Showing "Patient Privacy Rights Foundation" News Articles 1–25 of 13,000+

Wednesday 17th October 2018

Genome sequencing found feasible and informative for paediatric cancer treatment

Comprehensive genetic testing of tumours and non-cancerous tissue from paediatric cancer patients is a feasible and clinically useful approach that can guide patient care, according to findings presented at the American Society of Human Genetics (ASHG)...


[In Context] Adventures in Slumberland

In 1880, the French physician Jean-Baptiste-Édouard Gélineau described a 38-year-old man with severe bouts of sleepiness and episodes of muscle weakness when laughing out loud or anticipating a good business deal. Gélineau proposed the name narcolepsy, from the Greek narcosis (drowsiness) and lambanein (to take or to seize), to describe the patient's condition. More than 100 years later, Henry ...

MiNA Therapeutics Announces Sosei Will Not Exercise Acquisition Option

--MiNA Therapeutics remains on track with current development plans for small activating RNA medicines including clinical development of MTL-CEBPA drug candidate-- MiNA Therapeutics, the pioneer in RNA activation therapeutics, today announced that Sosei Group Corporation ("Sosei") has decided for strategic reasons not to exercise its option t...


AVITA Medical Announces First U.S. Sales of RECELL® System and Commencement of Commercial Shipping

Multiple U.S. burn centers incorporating RECELL System into their practices in advance of national U.S. market launch AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, today announced that it has received the first commercial

South Korea Airway and Anesthesia Procedures Outlook to 2025 [Report Updated: 01102018] Prices from USD $2995

South Korea Airway and Anesthesia Procedures Outlook to 2025SummaryGlobalData's new report, South Korea Airway and Anesthesia Procedures Outlook to 2024, provides key procedures data on the South Korea Airway and Anesthesia Procedures. The report provides procedure volumes within market segments Airway Management Procedures, Anesthesia Circuit Procedures, Anesthesia Mask Procedures, Breathing Bag...

SoCalBio Announces Lineup of Smart Wearable Device Companies to Present at 2nd Annual Digital Health Conference

15 Los Angeles-Area Ventures Will Debut Latest Smart Wearables for Fitness, Remote Monitoring, Disease Management and Healthcare Workflow The Southern California Biomedical Council (SoCalBio) today announced the lineup of companies that will present at its 2nd Annual Digital Conference, which will be held November 9 at Hotel Maya in Long Beach. ...

Gilead’s HIV Prevention Pill Can Greatly Reduce New Infections in Targeted Rollouts

(STAT News) – For the first time, a study has confirmed that using the HIV-prevention pill can effectively thwart the virus in uninfected men by a significant amount, a finding that patient activists argue should spur public health officials to … Read More

Exclusive: Science journal to withdraw chronic fatigue review amid patient activist complaints https://reut.rs/2CPj5AO 

Exclusive: Science journal to withdraw chronic fatigue review amid patient activist complaints https://reut.rs/2CPj5AO 

Intersect ENT to Report Third Quarter 2018 Financial Results

Intersect ENT, Inc. (NASDAQ:XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release third quarter financial results on November 5, 2018. The company expects to issue the release at approximately 7:00 a.m. ET and management will host a conference call at 8:00 a.m. ET. ...

Masimo to Report Third Quarter 2018 Financial Results after Market Close on Wednesday, October 31

Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) Masimo (NASDAQ: MASI) announced today that it will release third quarter 2018 financial results for the period ended September 29, 2018, after the market closes on Wednesday, October 31, 2018. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be ...

Prior PCI does little to affect CABG outcomes

Despite past research suggesting a history of percutaneous coronary intervention (PCI) could complicate coronary artery bypass grafting (CABG) outcomes, a study published in the Journal of the American Heart Association Oct. 16 reported prior PCI has little to do with how a patient recovers from subsequent surgeries.

American Academy of Otolaryngology, Oct. 7-10

The 122nd American Academy of Otolaryngology-Head and Neck Surgery Foundation Annual Meeting and OTO Experience The annual meeting of the American Academy of Otolaryngology-Head and Neck Surgery Foundation was held from Oct. 7 to 10 in Atlanta and...

MaxCyte doses first ovarian cancer patient in phase 1 clinical trial

MaxCyte Inc (LON:MXCT) CEO Doug Doerfler sat down with Proactive Investors' Christine Corrado at the Bio Investor Forum in San Francisco. Over the summer, the US FDA gave the company investigational new drug clearance for MCY-M11, a chimeric antigen receptor that targets solid tumours. Two weeks ago, the company began dosing its first patient. 

Mexico Cardiovascular Procedures Outlook to 2025 Cardiac Assist Procedures, Cardiac Rhythm Management CRM Procedures, Cardiovascular Surgery Procedures, Clot Management Procedures and Others [Report Updated: 10072018] Prices from USD $3995

Mexico Cardiovascular Procedures Outlook to 2025 Cardiac Assist Procedures, Cardiac Rhythm Management CRM Procedures, Cardiovascular Surgery Procedures, Clot Management Procedures and OthersSummaryGlobalData's new report, Mexico Cardiovascular Procedures Outlook to 2025, provides key procedures data on the Mexico Cardiovascular Procedures. The report provides procedure volumes within market categ...

CHARTER OF PATIENTS RIGHTS

The Union ministry of health has released a document entitled 'Charter of Patients Rights' early last month enlisting 17 basic rights of a patient.

Exclusive: Science journal to withdraw chronic fatigue review amid patient activist complaints

A respected science journal is to withdraw a much-cited review of evidence on an illness known as chronic fatigue syndrome (CFS) amid fierce criticism and pressure from activists and patients.

Echosens Observes October 2018 Liver Cancer Awareness Month: Know Your Risk for Nonalcoholic Fatty Liver Disease – A Looming National Epidemic

Supports greater awareness of high prevalence, disease risk factors, importance of early detection and impact on healthcare costs In support of Liver Cancer Awareness Month alongside the American Liver Foundation,

Pharmacy Quality Solutions Expands to Canadian Retail Pharmacy

PQS to work with Canada’s largest retail pharmacy network to help with patient-centered pharmacy quality initiatives Pharmacy Quality Solutions (PQS) today announced it will work with Loblaw Companies Limited, one of Canada’s largest retail pharmacy networks with Shoppers Drug Mart, PharmaPrix, Loblaw Pharmacy and DRUGStore Pharmacy and CENTRESante...

ACHC CEO José Domingos Named to Specialty Pharmacy Board

Domingos joins diverse group of experienced and accomplished health care veterans tasked with elevating the practice of specialty pharmacy Cary, NC (PRWEB) October 17, 2018 The National Association of Specialty Pharmacy (NASP) has named Accreditation Commission for Health Care (ACHC) President and CEO José Domingos to its board of directors. “The National Association of Specialty Pharmacy...

China Regional Anesthesia Procedures Outlook to 2025 [Report Updated: 01102018] Prices from USD $2995

China Regional Anesthesia Procedures Outlook to 2025SummaryGlobalData's new report, China Regional Anesthesia Procedures Outlook to 2024, provides key procedures data on the China Regional Anesthesia Procedures. The report provides procedure volumes within market segments Combined Spinal Epidural Disposable Procedures, Epidural Anesthesia Disposable Procedures, Peripheral Anesthesia Disposable Pr...

Healx Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17092018] Prices from USD $250

SummaryHealx Ltd Healx is a provider of drug repurposing solutions and combinational medicines for advancing the treatment of rare diseases. The company's technology combines biological data analysis with advanced machine learning algorithms to identify novel drug applications for rare diseases. It offers Rareomics, a tool that helps researchers, charities, and individuals keep up with the latest ...

India Knee Replacement Procedures Outlook to 2025 [Report Updated: 01082018] Prices from USD $2995

India Knee Replacement Procedures Outlook to 2025SummaryGlobalData's new report, India Knee Replacement Procedures Outlook to 2025, provides key procedures data on the India Knee Replacement Procedures. The report provides procedure volumes within market segments Primary Knee Replacement Procedures, Partial Knee Replacement Procedures and Revision Knee Replacement Procedures.The data in the repor...

Immune-Onc Therapeutics and University of Texas Report a Novel Target for Acute Myeloid Leukemia in Nature

Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a privately held cancer immunotherapy company dedicated to the discovery and development of novel biologic treatments for cancer patients, announced today the publication of a study in Nature (DOI: 10.1038/s41586-018-0615-z) that provi

RNA-based Technique Could Make Gene Therapy More Effective

NewsEngineers devised a way to regulate the expression of RNA once it gets into cells, giving them precise control over the dose of protein that a patient receives.

TenX Healthcare and Softbank to Collaborate on Developing Practical Innovations for Healthcare, Launching Projects in Data Visualization, Predictive Analytics, IoT, AI and Robotics

TenX Healthcare Launches Hawthorne PeriOp, Building on Proven Success in Cleveland Clinic Florida Pilot to Significantly Improve Key OR Performance Metrics TenX Healthcare, experts in improving productivity, efficiency and patient satisfaction, announced today that the company will work with


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks